» Articles » PMID: 30733048

The Predictive Value of Future Liver Remnant Function After Liver Resection for HCC in Noncirrhotic and Cirrhotic Patients

Overview
Journal HPB (Oxford)
Publisher Elsevier
Specialty Gastroenterology
Date 2019 Feb 9
PMID 30733048
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Surgical procedures in patients with underlying liver disease are still burdened by a high rate of postoperative morbidity, especially posthepatectomy liver failure (PHLF), ranging from 1.2 to 33.8%. The aim of this study was to investigate the prognostic value of volume/function analysis for the prediction of hepatectomy-related morbidity in patients with hepatocellular carcinoma.

Methods: Clinicopathological data were analysed in 261 patients who underwent liver resection for HCC between 2001 and 2014. Future liver remnant volume (FLRV) and future liver remnant function (FLRF) based on LiMAx test were obtained retrospectively. A subgroup analysis for high-risk patients with impaired liver function was conducted. Univariate and multivariate regression analysis was performed to identify risk factors for major complications, defined by Dindo ≥ IIIb and PHLF grade ≥ B.

Results: In the total cohort, FLRF was independently associated with major complications. FLRV, resected liver volume, and FLRF were independent risk factors for PHLF. In a subgroup analysis of high-risk patients, FLRF was identified as the only independent risk factor for major complications and PHLF development.

Discussion: These results suggest the superior value of FLRF to FLRV in predicting postoperative complications as well as PHLF in patients with chronic liver disease.

Citing Articles

Is conventional functional liver remnant volume higher than 40% still sufficient to prevent post-hepatectomy liver failure in jaundiced patients with hilar cholangiocarcinoma? A single-center experience in China.

Lv T, Ma W, Liu F, Hu H, Jin Y, Li F Cancer Med. 2024; 13(13):e7342.

PMID: 38967142 PMC: 11224912. DOI: 10.1002/cam4.7342.


Evaluation of liver regeneration after hemi-hepatectomy by combining computed tomography and post-operative liver function.

Shu W, Song Y, Lin Z, Yang M, Pan B, Su R Heliyon. 2024; 10(10):e30964.

PMID: 38803961 PMC: 11128876. DOI: 10.1016/j.heliyon.2024.e30964.


Current status of preoperative risk assessment for posthepatectomy liver failure in patients with hepatocellular carcinoma.

Nishio T, Taura K, Koyama Y, Ishii T, Hatano E Ann Gastroenterol Surg. 2023; 7(6):871-886.

PMID: 37927928 PMC: 10623981. DOI: 10.1002/ags3.12692.


Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.

Zhao M, Guo Z, Zou Y, Li X, Yan Z, Chen M Hepatol Int. 2023; 18(1):4-31.

PMID: 37864725 DOI: 10.1007/s12072-023-10599-6.


Postoperative Liver Failure: Definitions, Risk factors, Prediction Models and Prevention Strategies.

Merath K, Tiwari A, Court C, Parikh A, Dillhoff M, Cloyd J J Gastrointest Surg. 2023; 27(11):2640-2649.

PMID: 37783906 DOI: 10.1007/s11605-023-05834-2.